Navigator Guidance for Hearing Loss
(CHHIRP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help families with infants who have failed a hearing test receive care more quickly. It examines whether a patient navigator—a person who offers guidance and support—can expedite the testing process, ensure families adhere to appointment schedules, and educate parents about hearing loss. The trial includes two groups: one with a patient navigator and one without. Families with an infant who didn't pass a hearing screening at birth and require further testing at specific clinics in Kentucky may be suitable for this trial. As an unphased trial, it offers families the chance to contribute to research that may enhance care processes for infants with hearing loss.
Will I have to stop taking my current medications?
The trial protocol does not specify whether participants must stop taking their current medications.
What prior data suggests that this method is safe for children with hearing loss?
Research has shown that using a patient navigator to assist families of children with hearing loss is safe. Studies have found that patient navigators significantly help by ensuring families attend medical tests and appointments on time. They also provide support and information to parents, making it easier to understand their child's hearing loss.
No reports of negative effects from using patient navigators have emerged. Their role primarily involves supporting and guiding families through the healthcare process, without involving any medical procedures or medications. This suggests that the approach is well-received and poses no risk to participants.12345Why are researchers excited about this trial?
Researchers are excited about the Navigator Guidance for hearing loss because it introduces a personalized approach to managing the condition. Unlike standard treatments that primarily focus on medical or technological solutions, Navigator Guidance uses a human touch—guiding patients through their follow-up care with the help of a dedicated navigator. This approach aims to improve adherence to follow-up appointments, which is crucial for effective hearing loss management. By potentially increasing patient engagement and compliance, Navigator Guidance could enhance overall treatment outcomes, offering a fresh perspective on hearing health care.
What evidence suggests that this method is effective for improving pediatric hearing loss care?
This trial will compare the effectiveness of using a patient navigator versus no intervention for children with hearing loss. Research has shown that a patient navigator can greatly assist children with hearing loss. Studies have found that a patient navigator shortens the time it takes for children to receive necessary hearing tests after a problem is identified. This approach also increases the likelihood that families will keep their appointments. In one study, using a patient navigator reduced the time from discovering hearing loss to starting educational support and medical treatments. In short, patient navigators help families understand and manage their child's hearing condition better, leading to faster and more reliable care.12567
Who Is on the Research Team?
Matthew L Bush, MD, PhD
Principal Investigator
Associate Professor, Vice Chair of Research
Are You a Good Fit for This Trial?
This trial is for infants who failed a hearing screening in one or both ears before leaving the hospital after birth, and are referred for follow-up tests at specific clinics. It's also for parents who speak English or can use phone interpreting services. Families must live in Kentucky and not plan to move within three months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Standard of Care
Participants receive the standard of care before the introduction of patient navigation
Patient Navigation
Patient navigation is introduced to improve adherence to follow-up appointments and expand parental knowledge
Follow-up
Participants are monitored for adherence to follow-up appointments and diagnostic testing
What Are the Treatments Tested in This Trial?
Interventions
- Navigator Guidance
Find a Clinic Near You
Who Is Running the Clinical Trial?
Matthew Bush, MD
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
National Institutes of Health (NIH)
Collaborator